English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  50939551    在线人数 :  1150
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"su w c"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 51-60 / 419 (共42页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
國立成功大學 2022 A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Na�ve Patients with�EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China Tu, H.-Y.;Feng, J.;Shi, M.;Zhao, J.;Wang, Y.;Chang, J.;Wang, J.;Cheng, Y.;Zhu, J.;Tan, E.-H.;Li, K.;Zhang, Y.;Lee, V.;Yang, C.-T.;Su, W.-C.;Lam, D.C.-L.;Srinivasa, B.J.;Rajappa, S.;Ho, C.-L.;Lam, K.C.;Hu, Y.;Bondarde, S.A.;Liu, X.;Tian, Y.;Xue, Z.;Cseh, A.;Huang, D.C.-L.;Zhou, C.;Wu, Y.-L.
國立成功大學 2022 Final Overall Survival, Safety, and Quality of Life Results From a Phase 2 Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced NSCLC Wu, Y.-L.;Lu, S.;Yang, J.C.-H.;Zhou, J.;Seto, T.;Ahn, M.-J.;Su, W.-C.;Yamamoto, N.;Kim, D.-W.;Paolini, J.;Usari, T.;Iadeluca, L.;Wilner, K.D.;Goto, K.
國立成功大學 2022 Plasma contains ultrashort single-stranded DNA in addition to nucleosomal cell-free DNA Cheng, J.;Morselli, Morselli M.;Huang, W.-L.;Heo, Y.J.;Pinheiro-Ferreira, T.;Li, F.;Wei, F.;Chia, D.;Kim, Y.;He, He H.-J.;Cole, K.D.;Su, W.-C.;Pellegrini, M.;Wong, D.T.W.
國立成功大學 2022 Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan Chien, L.-H.;Chen, T.-Y.;Chen, Chen C.-H.;Chen, K.-Y.;Hsiao, C.-F.;Chang, G.-C.;Tsai, Y.-H.;Su, W.-C.;Huang, M.-S.;Chen, Y.-M.;Chen, Chen C.-Y.;Liang, S.-K.;Chen, Chen C.-Y.;Wang, C.-L.;Hung, Hung H.-H.;Jiang, H.-F.;Hu, J.-W.;Rothman, N.;Lan, Q.;Liu, T.-W.;Chen, Chen C.-J.;Yang, P.-C.;Chang, I.-S.;Hsiung, C.A.
國立成功大學 2022 Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: Results from a phase I/II open-label, multicenter study Zucali, P.A.;Lin, C.-C.;Carthon, B.C.;Bauer, T.M.;Tucci, M.;Italiano, A.;Iacovelli, R.;Su, W.-C.;Massard, C.;Saleh, M.;Daniele, G.;Greystoke, A.;Gutierrez, M.;Pant, S.;Shen, Y.-C.;Perrino, M.;Meng, R.;Abbadessa, G.;Lee, H.;Dong, Y.;Chiron, M.;Wang, R.;Loumagne, Loumagne L.;L�pine, L�pine L.;De, Bono J.
國立成功大學 2022 Rapid prototyping-assisted tooth autotransplantation is associated with a reduced root canal treatment rate: a retrospective cohort study Hwang, L.A.;Chang, Chang C.-Y.;Su, W.-C.;Chang, Chang C.-W.;Huang, C.-Y.
國立成功大學 2022 Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor– Resistant, EGFR-Mutated Non–Small Cell Lung Cancer J�nne, P.A.;Baik, C.;Su, W.-C.;Johnson, M.L.;Hayashi, Hayashi H.;Nishio, M.;Kim, D.-W.;Koczywas, M.;Gold, K.A.;Steuer, C.E.;Murakami, H.;Yang, J.C.-H.;Kim, S.-W.;Vigliotti, M.;Shi, R.;Qi, Z.;Qiu, Y.;Zhao, L.;Sternberg, D.;Yu, C.;Yu, H.A.
國立成功大學 2022 Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non–small cell lung cancer Santoro, A.;Su, W.-C.;Navarro, A.;Simonelli, M.;CH, Yang J.;Ardizzoni, Ardizzoni A.;Barlesi, F.;Hyoung, Kang J.;DiDominick, S.;Abdelhady, Abdelhady A.;Chen, X.;Stammberger, U.;Felip, E.
國立成功大學 2022 Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon Cancer Chuang, J.-P.;Tsai, H.-L.;Chen, P.-J.;Chang, T.-K.;Su, W.-C.;Yeh, Yeh Y.-S.;Huang, C.-W.;Wang, J.-Y.
國立成功大學 2022 Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial Lu, S.;Wang, Q.;Zhang, G.;Dong, X.;Yang, C.-T.;Song, Y.;Chang, G.-C.;Lu, Y.;Pan, H.;Chiu, Chiu C.-H.;Wang, Z.;Feng, J.;Zhou, J.;Xu, Xu X.;Guo, R.;Chen, J.;Yang, H.;Chen, Y.;Yu, Z.;Shiah, H.-S.;Wang, C.-C.;Yang, N.;Fang, J.;Wang, P.;Wang, K.;Hu, Y.;He, J.;Wang, Z.;Shi, J.;Chen, S.;Wu, Q.;Sun, C.;Li, C.;Wei, H.;Cheng, Y.;Su, W.-C.;Hsia, T.-C.;Cui, J.;Sun, Y.;Ou, S.-H.I.;Zhu, V.W.;Chih-Hsin, Yang J.

显示项目 51-60 / 419 (共42页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目